series-c-plus
Stage
1990
Founded
3
Investors
About
Insmed Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing medicines for patients with rare and serious diseases, utilizing innovative science including gene therapy and protein modification technologies.
Explore Insmed Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.